|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.02 CAD | -.--% |
|
-.--% | -.--% |
THC Biomed Intl Ltd. reported earnings results for the full year ended July 31, 2022. For the full year, the company reported sales was CAD 2.45 million compared to CAD 2.63 million a year ago. Net loss was CAD 3.07 million compared to CAD 6.36 million a year ago.
Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 2.4M | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| +0.09% | 1.65B | |
| -7.89% | 1.68B | |
| -12.97% | 1.53B | |
| +33.40% | 1.38B |
THC BIOMED INTL LTD. 
